Synonyms: | |
Status: | Approved (1996) |
Entry Type: | Small molecule |
Molecule Category: | Parent |
ATC: | J05AG01 |
UNII: | 99DK7FVK1H |
InChI Key | NQDJXKOVJZTUJA-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C15H14N4O |
Molecular Weight | 266.3 |
AlogP | 2.65 |
Hydrogen Bond Acceptor | 4.0 |
Hydrogen Bond Donor | 1.0 |
Number of Rotational Bond | 1.0 |
Polar Surface Area | 58.12 |
Molecular species | NEUTRAL |
Aromatic Rings | 2.0 |
Heavy Atoms | 20.0 |
Action | Mechanism of Action | Reference |
---|---|---|
INHIBITOR | Human immunodeficiency virus type 1 reverse transcriptase inhibitor | DailyMed |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Cytochrome P450
Cytochrome P450 family 2
Cytochrome P450 family 2C
Cytochrome P450 2C19
|
- | - | - | - | 12 | |
Enzyme
Hydrolase
|
4-9590 | 1-100000 | - | 300-36000 | 48-100 | |
Enzyme
Protease
Aspartic protease
Aspartic protease AA clan
Aspartic protease A2A subfamily
|
- | 101-57900 | - | - | - | |
Enzyme
|
4-9590 | 1-100000 | - | 300-36000 | 48-100 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
HIV Infections | 4 | D015658 | ClinicalTrials |
Infections | 3 | D007239 | ClinicalTrials |
Acquired Immunodeficiency Syndrome | 3 | D000163 | ClinicalTrials |
Tuberculosis | 3 | D014376 | ClinicalTrials |
Resources | Reference |
---|---|
ChEBI | 63613 |
ChEMBL | CHEMBL57 |
DrugBank | DB00238 |
DrugCentral | 1904 |
EPA CompTox | DTXSID7031797 |
FDA SRS | 99DK7FVK1H |
Human Metabolome Database | HMDB0014383 |
KEGG | C07263 |
PDB | NVP |
PharmGKB | PA450616 |
SureChEMBL | SCHEMBL3318 |
ZINC | ZINC000000004778 |